DLB vs. QGEN

Last updated Apr 2, 2026

Compare and contrast key facts about Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN).

Performance

DLB vs. QGEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN). The values are adjusted to include any dividend payments, if applicable.

DLB vs. QGEN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
DLB Dolby Laboratories, Inc.	-4.94%	-16.27%	-7.95%	23.82%	-24.90%	-0.99%	42.99%	12.63%	0.78%	38.73%
QGEN Qiagen N.V.	-10.36%	1.51%	2.44%	-12.91%	-10.27%	5.17%	56.36%	-1.89%	11.38%	10.49%

Fundamentals

Market Cap DLB : $5.86B QGEN : $8.39B
EPS DLB : $2.86 QGEN : $1.98
PE Ratio DLB : 21.23 QGEN : 20.41
PEG Ratio DLB : 31.33 QGEN : 0.17
PS Ratio DLB : 4.39 QGEN : 4.15
PB Ratio DLB : 2.26 QGEN : 2.22
Total Revenue (TTM) DLB : $1.34B QGEN : $2.09B
Gross Profit (TTM) DLB : $1.18B QGEN : $1.29B
EBITDA (TTM) DLB : $338.71M QGEN : $717.27M

Returns By Period

In the year-to-date period, DLB achieves a -4.94% return, which is significantly higher than QGEN's -10.36% return. Over the past 10 years, DLB has underperformed QGEN with an annualized return of 4.78%, while QGEN has yielded a comparatively higher 5.84% annualized return.

DLB

• 1D: 1.10%
• 1M: -6.76%
• YTD: -4.94%
• 6M: -14.95%
• 1Y: -23.20%
• 3Y*: -9.27%
• 5Y*: -8.51%
• 10Y*: 4.78%

QGEN

• 1D: 0.85%
• 1M: -17.30%
• YTD: -10.36%
• 6M: -12.97%
• 1Y: 2.59%
• 3Y*: -4.12%
• 5Y*: -3.86%
• 10Y*: 5.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DLB vs. QGEN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DLB

DLB Risk / Return Rank: 8
DLB Sharpe Ratio Rank: 6
DLB Sortino Ratio Rank: 8
DLB Omega Ratio Rank: 9
DLB Calmar Ratio Rank: 10
DLB Martin Ratio Rank: 7

QGEN

QGEN Risk / Return Rank: 40
QGEN Sharpe Ratio Rank: 43
QGEN Sortino Ratio Rank: 39
QGEN Omega Ratio Rank: 38
QGEN Calmar Ratio Rank: 41
QGEN Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DLB vs. QGEN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dolby Laboratories, Inc. (DLB) and Qiagen N.V. (QGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DLB	QGEN	Difference
Sharpe ratio Return per unit of total volatility	-0.92	0.08	-1.01
Sortino ratio Return per unit of downside risk	-1.23	0.39	-1.62
Omega ratio Gain probability vs. loss probability	0.85	1.05	-0.20
Calmar ratio Return relative to maximum drawdown	-0.84	0.03	-0.88
Martin ratio Return relative to average drawdown	-1.56	0.09	-1.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DLB vs. QGEN - Sharpe Ratio Comparison

The current DLB Sharpe Ratio is -0.92, which is lower than the QGEN Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of DLB and QGEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	DLB	QGEN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.92	0.08	-1.01
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.35	-0.16	-0.19
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.18	0.22	-0.04
Sharpe Ratio (All Time) Calculated using the full available price history	0.18	0.27	-0.09

Correlation

The correlation between DLB and QGEN is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DLB vs. QGEN - Dividend Comparison

DLB's dividend yield for the trailing twelve months is around 2.27%, less than QGEN's 6.32% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
DLB Dolby Laboratories, Inc.	2.27%	2.10%	1.57%	1.29%	1.45%	0.96%	0.91%	1.15%	1.08%	0.94%	1.11%	1.25%
QGEN Qiagen N.V.	6.32%	0.56%	2.96%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.36%	0.00%	0.00%

Drawdowns

DLB vs. QGEN - Drawdown Comparison

The maximum DLB drawdown since its inception was -62.19%, smaller than the maximum QGEN drawdown of -92.14%. Use the drawdown chart below to compare losses from any high point for DLB and QGEN.

Drawdown Indicators

	DLB	QGEN	Difference
Max Drawdown Largest peak-to-trough decline	-62.19%	-92.14%	+29.95%
Max Drawdown (1Y) Largest decline over 1 year	-27.12%	-29.81%	+2.69%
Max Drawdown (5Y) Largest decline over 5 years	-39.66%	-37.45%	-2.21%
Max Drawdown (10Y) Largest decline over 10 years	-39.66%	-38.61%	-1.05%
Current Drawdown Current decline from peak	-36.86%	-29.38%	-7.48%
Average Drawdown Average peak-to-trough decline	-22.22%	-47.45%	+25.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.67%	10.79%	+3.88%

Volatility

DLB vs. QGEN - Volatility Comparison

The current volatility for Dolby Laboratories, Inc. (DLB) is 6.76%, while Qiagen N.V. (QGEN) has a volatility of 8.43%. This indicates that DLB experiences smaller price fluctuations and is considered to be less risky than QGEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DLB	QGEN	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.76%	8.43%	-1.67%
Volatility (6M) Calculated over the trailing 6-month period	17.17%	22.91%	-5.74%
Volatility (1Y) Calculated over the trailing 1-year period	25.22%	30.93%	-5.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.60%	24.61%	-0.01%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.64%	26.81%	-0.17%

Financials

DLB vs. QGEN - Profitability Comparison

The chart below illustrates the profitability comparison between Dolby Laboratories, Inc. and Qiagen N.V. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DLB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Dolby Laboratories, Inc. reported a gross profit of 303.50M and revenue of 346.71M. Therefore, the gross margin over that period was 87.5%.

QGEN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Qiagen N.V. reported a gross profit of 317.27M and revenue of 540.42M. Therefore, the gross margin over that period was 58.7%.

DLB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Dolby Laboratories, Inc. reported an operating income of 62.16M and revenue of 346.71M, resulting in an operating margin of 17.9%.

QGEN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Qiagen N.V. reported an operating income of 153.90M and revenue of 540.42M, resulting in an operating margin of 28.5%.

DLB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Dolby Laboratories, Inc. reported a net income of 89.52M and revenue of 346.71M, resulting in a net margin of 25.8%.

QGEN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Qiagen N.V. reported a net income of 107.83M and revenue of 540.42M, resulting in a net margin of 20.0%.